These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33104044)
1. Lack of Association of Locus Coeruleus Pathology with Orthostatic Hypotension in Parkinson's Disease. Tong Q; Chen L J Parkinsons Dis; 2021; 11(1):233-237. PubMed ID: 33104044 [TBL] [Abstract][Full Text] [Related]
2. Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging? Palermo G; Galgani A; Bellini G; Lombardo F; Martini N; Morganti R; Paoli D; De Cori S; Frijia F; Siciliano G; Ceravolo R; Giorgi FS J Neural Transm (Vienna); 2024 Feb; 131(2):157-164. PubMed ID: 38032367 [TBL] [Abstract][Full Text] [Related]
3. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease. Prasuhn J; Prasuhn M; Fellbrich A; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Münte TF; Hanssen H; Heldmann M; Brüggemann N Neurology; 2021 Sep; 97(10):e1007-e1016. PubMed ID: 34187859 [TBL] [Abstract][Full Text] [Related]
4. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts. Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195 [TBL] [Abstract][Full Text] [Related]
5. Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients. Mills KA; Mari Z; Bakker C; Johnson V; Pontone GM; Pantelyat A; Troncoso JC; Pletnikova O; Dawson TM; Rosenthal LS Parkinsonism Relat Disord; 2016 Dec; 33():102-106. PubMed ID: 27693194 [TBL] [Abstract][Full Text] [Related]
6. Complex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra. Corradini BR; Iamashita P; Tampellini E; Farfel JM; Grinberg LT; Moreira-Filho CA Biomed Res Int; 2014; 2014():543673. PubMed ID: 25525598 [TBL] [Abstract][Full Text] [Related]
7. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association? McDonald C; Newton JL; Burn DJ Mov Disord; 2016 Jul; 31(7):937-46. PubMed ID: 27091624 [TBL] [Abstract][Full Text] [Related]
8. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505 [TBL] [Abstract][Full Text] [Related]
9. Locus Coeruleus atrophy doesn't relate to fatigue in Parkinson's disease. Solopchuk O; Sebti M; Bouvy C; Benoit CE; Warlop T; Jeanjean A; Zénon A Sci Rep; 2018 Aug; 8(1):12381. PubMed ID: 30120287 [TBL] [Abstract][Full Text] [Related]
10. High norepinephrinergic orthostatic hypotension in early Parkinson's disease. Umehara T; Oka H; Nakahara A; Matsuno H; Toyoda C Parkinsonism Relat Disord; 2018 Oct; 55():97-102. PubMed ID: 29880316 [TBL] [Abstract][Full Text] [Related]
11. Insular pathology in Parkinson's disease patients with orthostatic hypotension. Papapetropoulos S; Mash DC Parkinsonism Relat Disord; 2007 Jul; 13(5):308-11. PubMed ID: 16962365 [TBL] [Abstract][Full Text] [Related]
12. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease]. Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950 [TBL] [Abstract][Full Text] [Related]
13. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
14. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Zarow C; Lyness SA; Mortimer JA; Chui HC Arch Neurol; 2003 Mar; 60(3):337-41. PubMed ID: 12633144 [TBL] [Abstract][Full Text] [Related]
15. Cognition and transcranial sonography in Parkinson's disease patients with or without orthostatic hypotension. Wu JJ; Jin H; Shao YQ; Mao CJ; Chen J; Liu CF Brain Behav; 2021 Aug; 11(8):e2252. PubMed ID: 34291604 [TBL] [Abstract][Full Text] [Related]
16. Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story. Vermeiren Y; De Deyn PP Neurochem Int; 2017 Jan; 102():22-32. PubMed ID: 27899296 [TBL] [Abstract][Full Text] [Related]
17. Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson's disease and essential tremor. Wang X; Huang P; Haacke EM; Liu Y; Zhang Y; Jin Z; Li Y; Xu Q; Liu P; Chen S; He N; Yan F Neuroimage Clin; 2023; 38():103420. PubMed ID: 37141646 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X Magn Reson Imaging; 2014 Dec; 32(10):1301-6. PubMed ID: 25086330 [TBL] [Abstract][Full Text] [Related]
20. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mann DM; Yates PO Mech Ageing Dev; 1983 Feb; 21(2):193-203. PubMed ID: 6865505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]